The experience of Mylan, the pharmaceutical company under fire for hiking the price of a life-saving allergy medicine, reinforces the importance of competition in the marketplace, one of the country’s largest pharmacy benefit managers said. Read More »
.jpg)
The National Pharmaceutical Council (NPC) has announced that it will host a conference for health care stakeholders to discuss the effect of medical treatment on patient care and how the value of these treatments can be measured. Read More »
Recent survey results conducted by North Star Opinion Research and released by an industry association confirm that 60 percent of U.S. employers believe new federal oversight would lead to higher prescription-drug costs. Read More »
A ballot initiative supporters claim will lower drug prices in California is vague and poorly conceived, said a group with a long history of advocating for better cures and treatment for HIV and hepatitis C. Read More »
Amid the furor caused by the publicity surrounding Mylan's more than 400 percent price increase on the life-saving EpiPen, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt challenged the price-hike justification. Read More »
In the wake of a large jury verdict against Johnson & Johnson, the health products industry is closely watching a debate over expert witness standard legislation in Missouri. Read More »
The American Pharmacists Association (APhA) Foundation recently announced the recipients of its 2016 Pinnacle Awards. Read More »
Managing and monitoring the increasingly high cost of speciality drugs will be a key challenge to control insurance prices over the next two years, say employers and third party payers. Read More »
he Office of the National Coordinator for Health Information Technology (ONC), run by the U.S. Department of Health and Human Services (HHS), made a joint announcement with the Assistant Secretary for Preparedness and Response (ASPR) establishing funding opportunities for an Information Sharing and Analysis Organization (ISAO) for both the health care and public health sectors. Read More »
The fifth edition of the leading pharmaceutical compounding textbook was released last week. Read More »
TPP program rigorously evaluated teen prevention programs for effectiveness. Read More »
The American Pharmacists Association Academy of Student Pharmacists (APhA-ASP) will be hosting a program focused on leadership and professional development in collaboration with Amgen, Cardinal Health and Rite Aid on the weekend of July 15-17. Read More »
This week, Congress passed the Comprehensive Addiction and Recovery Act (CARA), which aims to combat prescription drug abuse, especially opioids. Read More »
Pharmacies required to follow nondiscrimination regulations when serving customers. Read More »
U.S. Rep. Fred Upton (R-MI), House Energy and Commerce Committee Chairman, and U.S. Rep. Joseph Pitts (R-PA), Health Subcommittee Chairman, continued their joint endeavor to obtain answers from the U.S. Food and Drug Administration (FDA) regarding its procedures to protect product trade secrets and confidential information in the food industry. Read More »
American consumers will be able to enjoy the benefits of drug competition that results in more choice and lower prices for life-saving drugs via the newly proposed Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, U.S. Sen. Chuck Grassley (R-Iowa) said. Read More »
A new report has been released summarizing up-to-date research that shows that 78 percent of new Medicaid enrollees have specified that without the Medicaid expansion to the Affordable Care Act (ACA), they would not have the resources to receive care on a regular basis. Read More »
A bipartisan bill introduced this week in the Senate would allow generic drug companies to sue the brand-name marketplace giants for samples and safety protocols. Read More »
The Pharmaceutical Care Management Association (PCMA) this week announced the next part of its campaign that explains the functions of pharmacy benefit managers (PBM). Read More »
New York State Senate is considering two bills that will exempt drugstores from safety and performance standards. Read More »
Alerts Sign-up
